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Letter to the Editor 
Giardiasis reactivation during severe SARS-CoV-2 infection  





SARS-CoV-2       
Dear Editor, 
Giardia spp. is a protozoan parasite that may inhabit the upper small 
intestine of mammals and is the aetiological agent of giardiasis, a self- 
limited illness in over 85% of affected individuals [1]. Giardiasis may 
be reactivated in immunocompromised hosts, thus indicating the 
effectiveness of normal host defence mechanisms against the parasite 
[1,2]. 
In December 2019, the severe acute respiratory syndrome corona-
virus 2 (SARS-CoV-2), was associated with a cluster of respiratory tract 
infections in Wuhan, Hubei province, China. It rapidly spread world-
wide, currently with more than 38.5 million confirmed cases and over 
1,000,000 deaths [3]. 
During the peak of contagion on April the 10th in Italy, a 66-year-old 
man was admitted to the hospital with an acute respiratory distress 
syndrome due to SARS-CoV-2 infection. He was rapidly transported in 
intensive care unit (ICU) with endotracheal intubation and mechanical 
ventilation. During the third week of hospitalization in ICU, eosinophils 
rose up to 24.9%, with an absolute count of 2970/mm3, without 
constitutional symptoms, except for unformed feces, and increased 
progressively. However, respiratory symptoms and lymphopenia were 
improving at that time of the ICU admission: pressure support 
decreased, mechanical ventilation was stopped, total lymphocytes 
raised from 630 at admission in ICU to 2050 cells/mm3) (Table 1). The 
diagnostic dilemma of hypereosinophilia was solved with ova, cysts and 
parasite tests, over three consecutive days, which revealed a positive 
antigen test for Giardia spp. and a large amount of trophozoites and cysts 
of Giardia lamblia in the stool test. Moreover, other bacteriological, 
virological and parasitological stool tests were negative. In the complex 
cascade of the immune system function, after careful epidemiological 
considerations, we therefore hypothized that some mechanisms may 
intertwine between the anti-giardiasis and the anti-SARS-CoV-2 
response. Upon administration of metronidazole, his hypereosinophilia 
improved returning to normal without recurrences (Table 1). Innate and 
adaptive immune responses were elicited in humans with Giardia spp. 
Moreover, this protozoan parasite does not invade epithelia, but it can 
induce local and systemic antibody and T-cell responses [1]. Early in 
giardiasis, operating defence mechanisms are B-cell-independent and 
include nitric oxide, reactive oxygen species, defensins, lactoferrins, and 
immune cells, such as phagocytes, mast cells, dendritic cells, and che-
mokines [2]. Subsequently, there is production of large amounts of 
parasite-specific IgA following infection, with the contribution of CD4+
T cell responses [1,2]. Among cytokines, interleukin (IL)-6 and IL-17 are 
important during Giardia infections in both animals and humans [1,2]. 
It has been suggested that the CD 4+ T cells play a double role during the 
anti-Giardia immune response. First, they activate and stimulate the 
differentiation of B cells to generate Giardia-specific antibodies. Second, 
they act through a B-cell-independent mechanism that is likely mediated 
by T-helper type 17 (Th17) cells [1,2]. 
Concerning SARS-CoV-2, infected patients may present with lym-
phopenia, but the disease has also been associated with immune hyper- 
responsiveness referred to as a cytokine storm [4,5]. The acute lung 
injury observed in patients with severe COVID-19 is characterized by 
inflammation and tissue damage in the respiratory tract that has is 
highly correlated to Th17 cell responses, as IL-17 can prompt the 
apoptosis of alveolar epithelial cells and the progression to pulmonary 
fibrosis [4,5]. 
It is well established that CD4+ T cells are essential for the clearance 
of Giardia, since T cell-deficient mice cannot control infections, whereas 
B cell-deficient mice can eliminate parasites. CD8+ T cells are not 
required for parasite clearance [1,2]. It is becoming increasingly evident 
that IL-17, within the context of a Giardia infection, is essential for 
protective immunity [1,2]. This pro-inflammatory cytokine is produced 
by Th17 cells that require both IL-6 and TGF-β for their development. IL- 
6 deficent mice fail to clear infections and also lack IL-17 expression, 
which suggests Th17 cells are required for parasite clearance in an IL-6 
dependent manner [1,2]. 
Cases in literature stated that giardiasis and hypereosinophilia as-
sociation are extremely rare but with a relatively good prognosis [6]. 
In our hypothesis, CD4+ T cells lymphopenia occurring in severe 
SARS-CoV-2 infected subjects may enable the avoidance of the clearance 
of Giardia lamblia infection or the development of invasive infection due 
to, albeit transitory, impaired immune response. High amounts of IL-17 
and IL-6 in the acute phase of SARS-CoV-2 infection, however, kept the 
infection at bay until the cytokine storm passed away in the recovery 
phase (Fig. 1). 
Based on these observations, the risk of reactivation of latent parasite 
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infection should be considered during SARS-CoV-2 infection, especially 
during the acute or recovery phase. 
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Table 1 
Blood cells count and main laboratory values between admission (Day 0) to discharge from Intensive Care Unit (Day 42).   
Day 0 Day 3 Day 7 Day 10 Day 14 Day 21 Day 28 Day 35 Day 42 
Total WBC count (× 10 × 9/L) 13,7 7,9 13 9,4 7,4 12,1 8 14 12 
Lymphocytes (absolute count) 940 630 580 540 620 3.230 1.870 2.040 2.050 
Eosinophils (absolute count) 4 34 2 30 790 2970 590 520 460 
LDH (U/L) 949 944 741 422 414 NA 599 489 422 
CRP (mg/L) 417 111 11 37 95 64 177 81 26 
PCT (ng/mL) 1,7 0,72 0,13 0,18 0,34 0,17 0,63 0,15 0,25 
IL-6 (pg/mL) 121 NA 360 NA NA 303 70,6 30,3 NA 
Ferritin (ng/mL) 2203 NA 1242 1653 NA NA NA 2066 NA 
Abbreviations: WBC, White Blood Cell; LDH, lactate dehydrogenases; CRP, C-reactive protein; PCT, procalcitonin; IL-6, interleuchin 6. 
Fig. 1. Hyphotetic trends in Lymphocites count, interleukins levels, viral and parasitic load during the different phases of SARS-CoV-2 infections.  
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